Metraipolis › archive › dc_688d09eba248

Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat — Europe PMC PMID:42364907

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/42364907
DOI
10.1016/j.tvr.2026.200346
License (as archived)
solo-consultazione
Archived
2026-10-18T16:01:29.672Z
SHA-256 of the archived text
186b32da36e88ed7561e6ceca23d0862307b99ca682bcd88cf98d3609c5d66a4
Stable URL of this page
https://metraipolis.com/documento/dc_688d09eba248

How to cite

Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat — Europe PMC PMID:42364907 — Europe PMC (en), https://europepmc.org/article/MED/42364907 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_688d09eba248 (Metraipolis archive dc_688d09eba248, sha256 186b32da36e88ed7561e6ceca23d0862307b99ca682bcd88cf98d3609c5d66a4)
BibTeX
@misc{dc688d09eba248,
  title = {Targeting EBV-associated gastric cancer by lytic induction therapy with nanatinostat — Europe PMC PMID:42364907},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/42364907},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_688d09eba248; sha256 186b32da36e88ed7561e6ceca23d0862307b99ca682bcd88cf98d3609c5d66a4},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/42364907. Agents can read the archived copy with the MCP tool read_document.